[Lemierre syndrome: several clinical features of "a forgotten disease"]

Esther Gargallo1, Jose Antonio Nuevo, Juan Carlos Cano

  • 1Servicio de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España. esthergargallo@yahoo.es

Abstract

Insights

Lemierre syndrome (LS) is a serious condition often overlooked. Prompt recognition of febrile pharyngeal symptoms and early treatment with antibiotics like carbapenems are crucial for reducing complications in young patients.

Area of Science:

  • Infectious Diseases
  • Emergency Medicine
  • Microbiology

Background:

  • Lemierre syndrome (LS) is a rare but severe thrombotic complication of a head and neck infection, often associated with anaerobic bacteria.
  • The incidence of LS has been suggested to be increasing due to changes in antibiotic prescribing patterns for oropharyngeal infections.
  • This study reviews recent cases of LS managed in an emergency department setting.

Purpose of the Study:

  • To review all cases of Lemierre syndrome diagnosed in an Emergency Department over a 5-year period.
  • To analyze the clinical presentation, diagnostic findings, management, and outcomes of LS patients.
  • To emphasize the importance of early diagnosis and appropriate treatment for Lemierre syndrome.

Main Methods:

  • Retrospective study of patients diagnosed with LS in the Emergency Department.
  • Data collected included patient demographics, clinical symptoms, laboratory results, radiological findings, treatment strategies, and patient outcomes.
  • Descriptive analysis was performed on the collected data.

Main Results:

  • Six patients with LS were identified, predominantly young males presenting with sore throat and pulmonary embolisms.
  • Complications included severe sepsis, acute renal failure, hemoptysis, and hydropneumothorax.
  • Antibiotic treatment, including carbapenems in three cases, was administered; anticoagulation was not consistently used without adverse events. No deaths were reported.

Conclusions:

  • Lemierre syndrome remains a condition with significant morbidity, necessitating high clinical suspicion in young individuals with febrile pharyngeal symptoms.
  • Early initiation of specific treatment, potentially including carbapenems, is vital to mitigate complications.
  • The study highlights the importance of considering LS in the differential diagnosis of severe head and neck infections with systemic manifestations.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...